IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 12657 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy
Suthinee Ithimakin,Pathra Theeratrakul,Apirom Laocharoenkiat,Akarin Nimmannit,Charuwan Akewanlop,Nopadol Soparattanapaisarn,Sirisopa Techawattanawanna,Krittiya Korphaisarn,Pongwut Danchaivijitr
Supportive Care in Cancer.2020;28(11)5335
[DOI]
2Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective
Ashok K. Vaid,Sudeep Gupta,Dinesh C. Doval,Shyam Agarwal,Shona Nag,Poonam Patil,Chanchal Goswami,Vikas Ostwal,Sagar Bhagat,Saiprasad Patil,Hanmant Barkate
Frontiers in Oncology.2020;10(11)5335
[DOI]
3Olanzapine: The Game-Changer “Antiemetic”
Manikandan Dhanushkodi
Indian Journal of Medical and Paediatric Oncology.2019;40(02)274
[DOI]
4Antiemetic Regimen with Olanzapine in Pediatric Patients Receiving Highly Emetogenic Chemotherapy
Azgar A. Rasheed,Sameer Bakhshi
Indian Journal of Medical and Paediatric Oncology.2021;42(04)366
[DOI]
5Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach
Jennifer Y. Sheng,Cesar A. Santa-Maria,Neha Mangini,Haval Norman,Rima Couzi,Raquel Nunes,Mary Wilkinson,Kala Visvanathan,Roisin M. Connolly,Evanthia T. Roussos Torres,John H. Fetting,Deborah K. Armstrong,Jessica J. Tao,Lisa Jacobs,Jean L. Wright,Elissa D. Thorner,Christine Hodgdon,Samantha Horn,Antonio C. Wolff,Vered Stearns,Karen L. Smith
JCO Oncology Practice.2020;16(10)665
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow